Table 2.
Knowledge of PV and ADRs (n = 342).
| Numbers | (%) | |
|---|---|---|
| Which of the following BEST defines PV? | ||
| The science and activities of detecting, assessing, understanding & preventing adverse effects (Correct) | 209 | (61.5) |
| The science of detecting the type & incidence of ADRs after a drug is marketed. | 55 | (16.2) |
| The process of improving the safety of drugs | 28 | (8.2) |
| The science of monitoring ADRs happening in a Hospital | 27 | (7.9) |
| Do not know | 21 | (6.2) |
| The purpose of PV | ||
| To enhance patients’ safety in relation to use of drugs (Correct) | 255 | (74.8) |
| To identify predisposing factors to ADRs | 24 | (7.0) |
| To identify unrecognized ADRs | 23 | (6.7) |
| To calculate incidence of ADRs | 15 | (4.4) |
| Do not know | 24 | (7.0) |
| Which of the following defines an ADR correctly? | ||
| Any noxious or undesired effect of a drug occurring at normal doses, during normal use (Correct) | 246 | (72.6) |
| Adverse health outcomes associated with inappropriate drug use | 55 | (16.2) |
| Harm resulting from the use of substandard/counterfeit drugs | 14 | (4.1) |
| Harm caused by drug overdose | 6 | (1.8) |
| Adverse outcomes associated with drug impurity | 5 | (1.5) |
| Other health problems associated with drug use | 13 | (3.8) |
| Which ADRs should be reported?a | ||
| All serious ADRs | 62 | (18.2) |
| ADRs to herbal and non-allopathic drugs | 1 | (.3) |
| ADRs to new drugs | 8 | (2.3) |
| ADRs to vaccines | 4 | (1.2) |
| Unknown ADRs to old drugs | 7 | (2.1) |
| All of the above (Correct) | 259 | (76.0) |
| Any center or ADR reporting system in Kuwait? | ||
| Yes | 24 | (7.0) |
| No | 317 | (93.0) |
PV: Pharmacovigilance; ADRs: Adverse Drug Reactions.
Numbers may not add to the total due to missing data.
a
Multiple responses were possible.